박병탁 기자

Park Pyeongtak

Reporter
Biowatch Team With a background in Business Administration (MBA), I focus on the pharmaceutical and biotech industries. My goal is to select key information and present it in an easily understandable manner.
mail ppt@kormedi.com

Latest Articles

MS Bio Pursues IPO to Fuel Expansion into Amniotic Lenses, Aesthetics, and Global Markets

Samsung Biologics Slashes Biopharma Development Timeline to 9.5 Months at BioProcess International 2026

Daewoong Pharmaceutical Enters Digital Therapeutics Market with Exclusive Deal for MCI Device 'Cogthera'

Daewoong Pharmaceutical Nears Completion of Phase 2 IPF Trial for Bersiporosin, Readout Set for H1 2027

GC Cell Administers Experimental CAR-NK Therapy at Seoul National University Hospital Following MFDS Approval

Exclusive: Boryung’s Spun-Off Sales Unit Sets Pay Above Parent Levels, Top 40% Eligible for 100 Million-Plus Won

Medytox’s Cholic Acid Fat-Reduction Injectable Nuviju Surpasses 30,000 Vials in Cumulative Supply

Immuncell-LC Demonstrates Potential in Preventing Liver Cancer Recurrence Following Organ Transplant

Previous1234Next